NeoSoul DNA token launched on BNB Chain as the native asset for an AI agent trading infrastructure project that raised $11 million in a Pre-A funding round announced on August 20, 2026. The token trades under the contract address 0xA991F61940095AEA0724ef54077223B048c5CF7b with the on-chain identifier DE NEO AGENT, according to project documentation.
The project centers on two products: NeoTrade, a local-first trading agent client for macOS and Windows that launched on August 17, and evoevo, a data preparation and evaluation engine. NeoSoul positions DNA as the operational currency for this agent economy, with a fixed supply cap of 1 billion tokens.
NeoSoul DNA Token Powers Agent Trading Infrastructure
NeoSoul's architecture addresses what it calls the Learning Gap and Execution Gap in AI trading. NeoTrade functions as the execution layer, allowing users to deploy trading agents that research markets, form judgments, place authorized orders, and leave observable records. The client supports live venues including Paper, predict.fun, and Polymarket.
The agent operates under user-defined constraints with Copilot and Auto approval modes, least privilege access, action logs, automatic pauses during anomalies, and a Kill Switch to halt operations immediately. Traders maintain the option to manually approve each proposal or enable automated execution within boundaries they set beforehand. Users prepay in-app usage credits with BSC-based USDT, keeping the payment address distinct from the trading wallet.
Skill Builder, which launched on September 1, enables traders to describe trading ideas in natural language and save them as reusable skills. The evoevo engine converts trading results into economic decision-making data that can be scored and improved, creating a feedback loop where the agent receives guidance from evidence, operates within user-set boundaries, generates outcome data, and uses that information to refine subsequent models.
Funding and Exchange Listings Mark NeoSoul DNA Token Debut
The $11 million Pre-A round announced on August 20 included backing from MH Ventures, Amber Group, ArkStream Capital, 0G Foundation, Kirin Capital, CatcherVC, and New Oak International. KuCoin and Bitget opened DNA/USDT spot trading pairs on October 16, with coverage from TechFlow and ChainCatcher positioning the token in a wider multi-venue spot debut during the same window.
CoinMarketCap shows a circulating supply of approximately 90 million DNA, representing 9% of the total supply. The token's CoinMarketCap UCID is 42524. Phemex Academy and other guides emphasize the standard trader rule for crowded tickers: verify the contract address before sizing positions.
The edgeX platform offers a DNAUSDC perpetual market pairing NeoSoul DNA against USDC collateral, with cross margin support, up to 10x leverage, a tick size of $0.0001, step size of 0.1 DNA, minimum order of 450 DNA, taker fees of 0.0450%, maker fees of 0.0400%, and a liquidation fee of 1.00%. The platform provides self-custody, KYC-free onboarding, and liquidity for DNA long and short positions.
Believe Plan Ties NeoSoul DNA Token to Product Settlement
The October 2026 Believe Plan introduces DNA-first product payments and KPI-gated team unlocks. NeoSoul states it will purchase DNA on the open market for salaries and partner compensation instead of drawing from locked treasury reserves. The project frames NeoTrade settlement for agents, skills, and data as requiring DNA exclusively, with technical partners who settle in the token receiving a 20% discount.
NeoSoul's FAQ positions DNA as payment for agent services, skill usage, data calls, and platform fees, along with governance participation and settlement between agents. The project explicitly states the token does not represent equity, does not provide a claim on profits, does not grant redemption rights, and does not promise returns. NeoSoul clarifies that it avoids holding user funds in custody, pooling assets, managing capital on a discretionary basis, distributing trading profits, or guaranteeing returns.
If NeoTrade fees, skill calls, and data usage settle in DNA, product adoption creates a demand path for the token. As adoption increases and payments settle in DNA, the token can function as an operational currency rather than a listing-week highlight. Conversely, if execution and evaluation occur but payments do not flow into DNA, the demand path weakens.
Trading Mechanics and Market Structure for NeoSoul DNA Token
The DNAUSDC market on edgeX opened after NeoTrade launched, the token debuted across multiple spot venues in mid-October, and the project rewrote its DNA-first Believe Plan. The market allows continuous expression of views on whether controlled execution and scoreable results translate into DNA payments after the initial listing period.
NeoSoul's website displays network counters including TOTAL AGENT, INTAKE AMOUNT, and TOKEN SPEND. The project's thesis is that DNA settlement should appear in actual product payments, not just announcement language, with DNA discounts for partners and open-market buying for salaries publicly visible on-chain.
Should open-market purchases, exclusive DNA settlement, and KPI gates advance together, the NeoSoul DNA token design carries more significance than a listing catalyst. If NeoTrade adoption grows and DNA-only settlement takes hold, the demand narrative strengthens. Under those conditions, the market would begin pricing DNA as an operational currency with sustained momentum instead of a temporary spike driven by listing week attention.
The risk case is that initial attention across multiple venues dissipates before fee demand materializes to replace it, and the market begins to treat DNA as generic AI beta. The token's value proposition depends on whether the agent economy generates measurable economic activity that flows through DNA settlement.
Product Loop and Verifiable History Define NeoSoul Approach
NeoSoul did not arrive as a blank brochure. The project has dated shipping milestones, named capital, live products addressing both learning and execution challenges, and a spot wave in mid-October. The DNAUSDC market provides traders a way to bet on whether those achievements will keep building into sustained DNA demand.
The project's argument is to connect the learning side and the execution side within the same system. Demonstrating intelligence falls short; what matters is whether it registers as a quantifiable economic activity. Market participants seek evidence of bounded actions and traceable records rather than displays of capability.
NeoSoul aims to build infrastructure for the agent economy rather than an opaque fund dressed in AI terminology. The goal is agents that can be trusted economic entities: measurable, controllable, accountable, with humans remaining the principals. This is a commercial bet, not a pitch for theater.
Conclusion
NeoSoul DNA token entered the market in mid-October 2026 with $11 million in backing, live products in NeoTrade and evoevo, and spot listings on KuCoin and Bitget. The token's design ties demand to product settlement through the Believe Plan's DNA-first payment structure and open-market purchasing for operations.
The next concrete milestone is whether DNA settlement appears in actual product payments as NeoTrade adoption develops. Traders can monitor the token's performance on the edgeX DNAUSDC perpetual market and track whether the agent economy generates sustained fee demand that flows through DNA.
Frequently Asked Questions
What is the NeoSoul DNA token contract address on BNB Chain?
The NeoSoul DNA token contract address on BNB Chain is 0xA991F61940095AEA0724ef54077223B048c5CF7b, with the on-chain name DE NEO AGENT. The token's CoinMarketCap UCID is 42524. Traders should verify this contract address before sizing positions, as crowded tickers require confirmation of the correct on-chain identifier.
When did NeoSoul announce its $11 million Pre-A funding round?
NeoSoul announced an $11 million Pre-A funding round on August 20, 2026. The round included backing from MH Ventures, Amber Group, ArkStream Capital, 0G Foundation, Kirin Capital, CatcherVC, and New Oak International. This funding preceded the NeoTrade product launch on August 17 and the mid-October exchange listings.
What exchanges listed NeoSoul DNA token in October 2026?
KuCoin and Bitget opened DNA/USDT spot trading pairs on October 16, 2026. TechFlow and ChainCatcher coverage placed DNA within a broader multi-venue spot debut during that period. The edgeX platform also offers a DNAUSDC perpetual market with up to 10x leverage.
What is the total supply cap for NeoSoul DNA token?
NeoSoul DNA token has a total supply capped at 1,000,000,000 DNA. CoinMarketCap data indicates roughly 90 million DNA in circulation, which equals 9% of the total supply. The token is designed as the operational currency for NeoSoul's agent economy, not as equity or a claim on profits.
What is the NeoSoul Believe Plan announced in October 2026?
The Believe Plan is NeoSoul's October 2026 initiative introducing DNA-first product payments and KPI-gated team unlocks. NeoSoul will purchase DNA on the open market for salaries and partner compensation rather than paying from locked treasury. NeoTrade settlement for agents, skills, and data is DNA-only, with technical partners receiving a 20% discount for settling in DNA.
Sources
